A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma
Durand, Manon, Cabaud Gibouin, Vincent, Duplomb, Laurence, Salmi, Leila, Caillot, Mélody, Sola, Brigitte, Camus, Vincent, Jardin, Fabrice, Garrido, Carmen, Jego, Gaëtan
Published in Journal of experimental & clinical cancer research (22.05.2024)
Published in Journal of experimental & clinical cancer research (22.05.2024)
Get full text
Journal Article
P1217: TARGETING HSP110 IN COMBINATION WITH SELINEXOR IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA AND IN CLASSICAL HODGKIN LYMPHOMA INHIBITS STAT6 ACTIVATION AND IMPAIRS LYMPHOMA CELL GROWTH
Durand, Manon, Cabaud Gibouin, Vincent, Camus, Vincent, Salmi, Leila, Duplomb, Laurence, Viailly, Pierre‐Julien, Jardin, Fabrice, Sola, Brigitte, Garrido, Carmen, Jego, Gaetan
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
HSP110 sustains chronic NF-κB signaling in activated B-cell diffuse large B-cell lymphoma through MyD88 stabilization
Boudesco, Christophe, Verhoeyen, Els, Martin, Laurent, Chassagne-Clement, Catherine, Salmi, Leila, Mhaidly, Rana, Pangault, Céline, Fest, Thierry, Ramla, Selim, Jardin, Fabrice, Wolz, Olaf-Oliver, Weber, Alexander N.R., Garrido, Carmen, Jego, Gaetan
Published in Blood (02.08.2018)
Published in Blood (02.08.2018)
Get full text
Journal Article